Skip to main content
Premium Trial:

Request an Annual Quote

For Quick Updates

The US Food and Drug Administration is looking into enabling companies that have developed SARS-CoV-2 vaccines to quickly update them to cope with new viral variants, Business Insider reports.

Recent studies have indicated that currently authorized vaccines and ones that recently reported late-stage testing results may be less effective against new SARS-CoV-2 strains, particularly the one recently identified in South Africa. Some vaccines developers have said they could, if necessary, update their SARS-CoV-2 vaccines to encompass new viral variants or provide a booster to existing vaccines.

According to Business Insider, Janet Woodcock, the acting head of the US Food and Drug Administration, says the agency will be using the framework it relies on for the flu to develop a guidance for vaccine makers on how to quickly update their SARS-CoV-2 vaccines without having to conduct clinical trials with tens of thousands of people.

She notes, according to the Wall Street Journal, that such vaccine updates don't yet look necessary. "With current vaccines, we feel that, against any variants we have seen, we have a fair amount of confidence they will provide good protection," she said during a press briefing, according to the Journal, but added that "we must prepare for all eventualities. The situation could change, and it could change pretty rapidly."

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.